Volume: 2 Issue: 1
Year: 2025, Page: 34-38, Doi: https://doi.org/10.71325/ajjms.v2i1.24.13
Received: Feb. 5, 2025 Accepted: April 3, 2025 Published: April 19, 2025
Introduction: Hepatic encephalopathy (HE) is a severe neuropsychiatric complication in patients with liver cirrhosis, and hyponatremia is a critical factor influencing its progression. This study aims to evaluate the role of serum sodium levels in predicting the severity and outcomes of HE. Methodology: This observational study was conducted at A.J. Institute of Medical Sciences, Mangalore, over two years, including 97 HE patients aged 21 and above. Patients with Grade 2-4 HE, as per the West Haven criteria, were included. Sodium levels were measured on Days 0, 2, 4, and 7, and statistical analyses were performed to assess changes in sodium levels and their association with clinical outcomes. Results: The mean sodium level decreased from 126.79 mEq/L on Day 0 to 122.20 mEq/L on Day 7. Patients discharged against medical advice (DAMA) showed a mean sodium decrement of 6.00 mEq/L, while those who expired had a larger decrease of 10.59 mEq/L. In contrast, improved patients exhibited a mean sodium increase of 12.70 mEq/L. The variation in sodium levels across these groups was statistically significant (p<0.001). Lower sodium levels were associated with poorer outcomes, while rising sodium levels correlated with recovery. Conclusion: This study highlights that serum sodium levels are a significant predictor of morbidity and mortality in HE patients. Regular monitoring and timely correction of sodium imbalances are crucial for improving patient outcomes. Future research should focus on therapeutic strategies to manage hyponatremia and its systemic effects in HE patients.
Keywords: Hepatic encephalopathy, Hyponatremia, Serum sodium, Liver cirrhosis, Patient outcomes, Morbidity, Mortality
Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterology and Hepatology. 2022;7(8 ):724–735. Available from: https://doi.org/10.1016/s2468-1253(22)00050-4
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology. 2006;44(1):217–231. Available from: https://doi.org/10.1016/j.jhep.2005.10.013
Liu ZP, Ouyang GQ, Huang GZ, Wei J, Dai L, He SQ, et al. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019. World Journal of Hepatology. 2023;15(11):1210–1225. Available from: https://doi.org/10.4254/wjh.v15.i11.1210
Jepsen P, Younossi ZM. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. Journal of Hepatology. 2021;75(Suppl 1):3–13. Available from: https://doi.org/10.1016/j.jhep.2020.11.042
Wang Y, Huang Y, Chase RC, Li T, Ramai D, Li S, et al. Global burden of digestive diseases: A systematic analysis of the global burden of diseases study. Gastroenterology. 2023;165(3):773–783. Available from: https://doi.org/10.1053/j.gastro.2023.05.050
Koola JD, Ho SB, Cao A, Chen G, Perkins AM, Davis SE, et al. Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis. Digestive Diseases and Sciences. 2020;65(4):1003–1031. Available from: https://doi.org/10.1007/s10620-019-05826-w
Wei M, Ford J, Li Q, Jeong D, Kwong AJ, Nguyen MH, et al. Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California. Digestive Diseases and Sciences. 2018;63(9):2267–2274. Available from: https://doi.org/10.1007/s10620-018-4964-0
Guevara M, Baccaro ME, Ríos J, Martín-Llahí M, Uriz J, Arbol LRD, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver International. 2010;30(8):1137–1142. Available from: https://doi.org/10.1111/j.1478-3231.2010.02293.x
Patel R, Poddar P, Choksi D, Pandey V, Ingle M, Khairnar H, et al. Predictors of 1-month and 3-months hospital readmissions in decompensated cirrhosis: a prospective study in a large Asian cohort. Annals of Hepatology. 2019;18(1):30–39. Available from: https://doi.org/10.5604/01.3001.0012.7859
Bossen L, Ginès P, Vilstrup H, Watson H, Jepsen P. Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites. Journal of Gastroenterology and Hepatology. 2019;34(5):914–920. Available from: https://doi.org/10.1111/jgh.14558
Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology. 2015;63(5):1272–1284. Available from: https://doi.org/10.1016/j.jhep.2015.07.004
Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019;79(Suppl 1):5–9. Available from: https://doi.org/10.1007/s40265-018-1018-z
Kim JH, Lee JS, Lee SH, Bae WK, Kim NH, Kim KA, et al. The association between the serum sodium level and the severity of complications in liver cirrhosis. Korean Journal of Internal Medicine. 2009;24(2):106–112. Available from: https://doi.org/10.3904/kjim.2009.24.2.106
Maqsood S, Saleem A, Iqbal A, Butt JA. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute of Medical Sciences, Islamabad. Journal of Ayub Medical College Abbottabad. 2006;18(4):58–62. Available from: https://pubmed.ncbi.nlm.nih.gov/17591012/
Guevara M, Baccaro ME, Torre A, Gómez-Ansón B, Ríos J, Torres F, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. American Journal of Gastroenterology. 2009;104(6):1382–1389. Available from: https://doi.org/10.1038/ajg.2009.293
Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, et al. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. Journal of Hepatology. 2013;59(3):467–473. Available from: https://doi.org/10.1016/j.jhep.2013.04.023
© 2025 Published by Laxmi Memorial Education Trust. This is an open-access article under CC BY 4.0 license. (https://creativecommons.org/licenses/by/4.0/)
Pruthweesh H Hegde, Nagaraj Shetty, Druva D Shetty. Correlation Between Serum Sodium and Worsening of Hepatic Encephalopathy. AJ J Med Sci 2025;2(1):34–38